These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12147668)

  • 41. Increased oxidized low density lipoprotein associated with high ceruloplasmin activity in patients with active acromegaly.
    Boero L; Cuniberti L; Magnani N; Manavela M; Yapur V; Bustos M; Gómez Rosso L; Meroño T; Marziali L; Viale L; Evelson P; Negri G; Brites F
    Clin Endocrinol (Oxf); 2010 May; 72(5):654-60. PubMed ID: 19681912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Acromegaly and pregnancy].
    Bétéa D; Valdes Socin H; Hansen I; Stevenaert A; Beckers A
    Ann Endocrinol (Paris); 2002 Oct; 63(5):457-63. PubMed ID: 12442089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Serum lipids in patients with acromegaly].
    Padrón RS; Licea M; Hung S
    Rev Clin Esp; 1980 Dec; 159(6):413-5. PubMed ID: 7221109
    [No Abstract]   [Full Text] [Related]  

  • 44. Pitfalls in the diagnosis of acromegaly.
    Pokrajac-Simeunovic A; Trainer PJ
    Horm Res; 2004; 62 Suppl 3():74-8. PubMed ID: 15539804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.
    Trainer PJ; Drake WM; Katznelson L; Freda PU; Herman-Bonert V; van der Lely AJ; Dimaraki EV; Stewart PM; Friend KE; Vance ML; Besser GM; Scarlett JA; Thorner MO; Parkinson C; Klibanski A; Powell JS; Barkan AL; Sheppard MC; Malsonado M; Rose DR; Clemmons DR; Johannsson G; Bengtsson BA; Stavrou S; Kleinberg DL; Cook DM; Phillips LS; Bidlingmaier M; Strasburger CJ; Hackett S; Zib K; Bennett WF; Davis RJ
    N Engl J Med; 2000 Apr; 342(16):1171-7. PubMed ID: 10770982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of radiotherapy in acromegaly.
    González B; Vargas G; Espinosa-de-los-Monteros AL; Sosa E; Mercado M
    Arch Med Res; 2011 Jan; 42(1):48-52. PubMed ID: 21376263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Somatotropin in the blood in acromegaly].
    GEMZELL CA; HEIJKENSKJOLD F; STROM L
    Nord Med; 1956 Oct; 56(43):1562-3. PubMed ID: 13388125
    [No Abstract]   [Full Text] [Related]  

  • 48. Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice.
    Bielohuby M; Roemmler J; Manolopoulou J; Johnsen I; Sawitzky M; Schopohl J; Reincke M; Wolf E; Hoeflich A; Bidlingmaier M
    Exp Biol Med (Maywood); 2009 Aug; 234(8):1002-9. PubMed ID: 19491373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
    Freda PU; Nuruzzaman AT; Reyes CM; Sundeen RE; Post KD
    J Clin Endocrinol Metab; 2004 Feb; 89(2):495-500. PubMed ID: 14764751
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly.
    Bastemir M; Akin F; Yaylali GF
    Neuroendocrinology; 2007; 86(2):119-23. PubMed ID: 17671378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Excessively high soluble Klotho in patients with acromegaly.
    Sze L; Bernays RL; Zwimpfer C; Wiesli P; Brändle M; Schmid C
    J Intern Med; 2012 Jul; 272(1):93-7. PubMed ID: 22452701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Serum adiponectin levels in patients with acromegaly].
    Siemińska L; Lenart J; Cichoń-Lenart A; Niedziołka D; Marek B; Kos-Kudła B; Kajdaniuk D; Nowak M
    Pol Merkur Lekarski; 2005 Oct; 19(112):514-6. PubMed ID: 16379314
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transsphenoidal surgery in patients with acromegaly: operative strategies for overcoming technically challenging anatomical variations.
    Zada G; Cavallo LM; Esposito F; Fernandez-Jimenez JC; Tasiou A; De Angelis M; Cafiero T; Cappabianca P; Laws ER
    Neurosurg Focus; 2010 Oct; 29(4):E8. PubMed ID: 20887133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimizing Blood Sampling Protocols in Patients With Acromegaly for the Estimation of Growth Hormone Secretion.
    Roelfsema F; Biermasz NR; Pereira AM; Veldhuis JD
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2675-82. PubMed ID: 27023448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up.
    Dimaraki EV; Jaffe CA; DeMott-Friberg R; Chandler WF; Barkan AL
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3537-42. PubMed ID: 12161471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Algorithmic complexity of growth hormone release in humans.
    Prank K; Wagner M; Brabant G
    Pac Symp Biocomput; 1997; ():352-60. PubMed ID: 9390305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fibrin stabilizing factor activity of the skin carcinoma.
    Bernecka I; Klepacki A; Ostrowska H
    Rocz Akad Med Bialymst (1989); 1992; 37():3-7. PubMed ID: 1286138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Novel pharmacologic therapies in acromegaly].
    Góth M; Hubina E; Kovács L; Szabolcs I
    Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GH and mortality in acromegaly.
    Sheppard MC
    J Endocrinol Invest; 2005; 28(11 Suppl International):75-7. PubMed ID: 16625851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.